Canada markets closed

Sino Biopharmaceutical Limited (1177.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
2.880-0.010 (-0.35%)
As of 11:01AM HKT. Market open.
Currency in HKD

Valuation Measures4

Market Cap (intraday) 54.31B
Enterprise Value 52.65B
Trailing P/E 26.22
Forward P/E 19.12
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.90
Price/Book (mrq)1.65
Enterprise Value/Revenue 2.01
Enterprise Value/EBITDA 7.54

Trading Information

Stock Price History

Beta (5Y Monthly) 0.52
52-Week Change 3-30.19%
S&P500 52-Week Change 324.49%
52 Week High 34.260
52 Week Low 32.290
50-Day Moving Average 32.928
200-Day Moving Average 33.096

Share Statistics

Avg Vol (3 month) 352.41M
Avg Vol (10 day) 361.95M
Shares Outstanding 518.79B
Implied Shares Outstanding 618.79B
Float 89.28B
% Held by Insiders 148.19%
% Held by Institutions 115.69%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.05
Forward Annual Dividend Yield 41.73%
Trailing Annual Dividend Rate 30.05
Trailing Annual Dividend Yield 31.56%
5 Year Average Dividend Yield 41.44
Payout Ratio 472.63%
Dividend Date 3N/A
Ex-Dividend Date 4Jun 11, 2024
Last Split Factor 23:2
Last Split Date 3Jul 20, 2020

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 8.90%
Operating Margin (ttm)20.76%

Management Effectiveness

Return on Assets (ttm)5.33%
Return on Equity (ttm)12.12%

Income Statement

Revenue (ttm)26.2B
Revenue Per Share (ttm)1.41
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA 6.38B
Net Income Avi to Common (ttm)1.85B
Diluted EPS (ttm)0.110
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.12B
Total Cash Per Share (mrq)0.77
Total Debt (mrq)12.72B
Total Debt/Equity (mrq)33.31%
Current Ratio (mrq)1.05
Book Value Per Share (mrq)1.66

Cash Flow Statement

Operating Cash Flow (ttm)6.07B
Levered Free Cash Flow (ttm)3.01B